Australia provides a safe, stable and straightforward environment in which to undertake your clinical development program:
- Advantageous regulatory environment (no IND required).
- Short start-up timelines due to seamless central ethics approval process. (WEBSITE)
- Quick, inexpensive and efficient regulatory notification scheme. (CTN) (WEBSITE)
- Standard Medicines Australia Clinical Trial Agreement templates. (WEBSITE)
- Mature and robust healthcare system.
- Access to R&D tax credit scheme. (WEBSITE)
- Experienced global standard clinical researchers.
- Access to world-class neuroscience practitioners.
- Motivated patient populations.